We describe and functionally characterize six mutations of the acetylcholine receptor (AChR) ε subunit gene in three congenital myasthenic syndrome patients. Endplate studies demonstrated severe endplate AChR deficiency, dispersed endplate regions and well preserved junctional folds in all three patients. Electrophysiologic studies were consistent with expression of the fetal γ-AChR at the endplates in one patient, prolongation of some channel events in another and γ-AChR expression as well as some shorter than normal channel events in still another. Genetic analysis revealed two recessive and heteroallelic ε subunit gene mutations in each patient. One mutation in each (εC190T [εR64X], ε127ins5 and ε553del7) generates a nonsense codon that predicts truncation of the ε subunit in its N-terminal, extracellular domain; and one mutation in each generates a missense codon (εR147L, εP245L and εR311W). 
INTRODUCTION
Congenital myasthenic syndromes (CMS) are heterogeneous disorders in which the safety margin of neuromuscular transmission is compromised by one or more specific mechanisms (1) . The CMS identified to date include endplate (EP) acetylcholinesterase (AChE) deficiency (2, 3) , presynaptic abnormalities that affect the release (4) or size (5) of transmitter quanta, or postsynaptic abnormalities associated with marked deficiency of the acetylcholine receptor (AChR), a kinetic abnormality of the AChR or both (1, (6) (7) (8) .
The adult AChR is a pentamer of homologous subunits with the composition of α 2 βδε. We hypothesized (1, 9) and subsequently confirmed (10) (11) (12) (13) ) that a kinetic abnormality of AChR detected at the single channel level predicts a mutation involving one or more of its subunits. Kinetically abnormal mutations have been identified in the α, β and ε subunits, and do not reduce AChR expression appreciably (10) (11) (12) (13) . We also posited that a severe deficiency of AChR could stem from nonsense mutations in one or more AChR subunit genes, although severe EP AChR deficiency also could result from primary defects in mechanisms that regulate the synthesis, aggregation, cytoskeletal attachment and metabolic stability of EP AChR (14) (15) (16) (17) (18) . We confirmed this notion by discovery of nonsense mutations in the ε subunit gene that cause severe EP AChR deficiency (19) (20) (21) (22) .
Here we report and functionally characterize six mutations of the AChR ε subunit gene in three CMS patients who have severe *To whom correspondence should be addressed. Tel: +1 507 284 5102; Fax: +1 507 284 5831; Email: age@mayo.edu EP AChR deficiency. Each patient carries a nonsense and a missense mutation on different alleles of the ε subunit gene. Each nonsense mutation predicts truncation of the ε subunit in its extracellular domain, and expression studies in HEK cells indicate that these are null mutations. Each missense mutation significantly reduces AChR expression, two of the missense mutations result in kinetic abnormalities of the AChR and one missense mutation is kinetically benign.
We also describe compensatory mechanisms that mitigate the effects of these mutations in the ε subunit. Normally, fetal AChR is present at human EPs until the 31st week of gestation, reappears following denervation, is suppressed by nerve contact or electrical activity and contains a γ in place of an ε subunit. γ-AChR is readily distinguished from ε-AChR by its smaller single channel current amplitude and increased mean open duration (23, 24) . In two of the three patients, we detected significant γ-AChR that appeared to compensate for deficiency of ε-AChR.
RESULTS

Patients
All three CMS patients had myasthenic symptoms since the neonatal period. Patient 1, an 11-year-old male, had decreased movements in utero, a weak cry and a feeble suck after birth, ptosis of the eyelids since 5 months of age and ophthalmoparesis by the age of 2 years. He always fatigued easily, could never run well and had difficulty climbing steps. Patient 2, an 8-year-old female, had a weak cry at birth, ptosis since the age of 8 months and ophthalmoparesis since the age of 2 years. She learned to walk at the age of 18 months, always fatigued easily and could not run. Patient 3, a 31-year-old female, had a poor suck and cry after birth, ptosis in the neonatal period and breathing and swallowing difficulties at 4 months of age. Since then she had numerous episodes of impaired respiration and fatigued easily on exertion. She could not run, climbed steps with difficulty and could walk only a few hundred yards without having to rest. Patients 1 and 2 both have a similarly affected sibling. Patient 3 has no history of similarly affected relatives. All three have negative tests for anti-AChR antibodies, a decremental electromyographic response on stimulation of motor nerves and respond favorably but incompletely to AChE inhibitors.
Endplate studies EP morphology. This was similar in the three patients. The configuration of the EPs, evaluated from the cytochemical reaction product for AChE on teased single muscle fibers, was abnormal, with an increased number of small EP regions distributed over a 3-to 7-fold increased span of the muscle fiber surface ( Fig. 1A and B) . Electron microscopy revealed that the structural integrity of most EPs was well preserved; a few junctional folds were degenerating in patient 2, the junctional sarcoplasm harbored a few myeloid structures in patients 2 and 3, and in all three patients some postsynaptic regions appeared simplified (Fig. 1C) . At individual EP regions, the mean nerve terminal size was reduced to 59, 65 and 42% and the mean area of junctional folds and clefts to 45, 44 and 29% of normal. However, owing to the increased number of regions per EP, the total nerve terminal and postsynaptic volumes per EP were probably greater rather than smaller than normal.
EP AChR deficiency.
This was established by several measures. The reaction for AChR, detected by fluorescence microscopy with rhodamine-labeled α-bungarotoxin (α-bgt) and by electron microscopy with peroxidase-labeled α-bgt ( Fig. 1C and D) , was markedly attenuated. The AChR index [defined as the ratio of the postsynaptic membrane reacting for AChR to the length of the primary synaptic cleft (25) ] was only 14-23% of the control mean (Table 1 ) and the reaction for AChR on the junctional folds was patchy as well as of reduced intensity (Fig. 1C) . The number of [ 125 I]α-bgt-binding sites per EP was also markedly decreased (Table 1) . Finally, the amplitudes of the miniature EP potential (MEPP) and of the miniature EP current (MEPC) were decreased to 8-26% and to 20-42% of normal, consistent with EP AChR deficiency. These values, however, may represent overestimates as the smallest potentials and currents were probably lost in the baseline noise. The number of transmitter quanta released by nerve impulse was normal in patient 1 but was increased in patients 2 and 3, perhaps as an adaptive response to decreased postsynaptic sensitivity to acetylcholine (ACh) (26, 27) (Table 1 ). (Fig. 2) . Less than 1% of the recorded channel events resembled those found at normal EPs. These findings suggest that the EP AChRs contain mostly the fetal γ subunit (γ-AChR) in place of the adult ε subunit (ε-AChR) (23) but that mutant AChR channels are probably also expressed.
In patient 2, the τ MEPC was mildly prolonged. Patch-clamp recordings captured only 442 channel openings at four EPs. These channels opened to a normal conductance. The open intervals and bursts of openings had a very brief minor and a longer major component, similar to those at the control EPs, and a third component that was 2-fold longer than normal (Fig. 2) . Even these limited observations indicate the presence of a kinetically abnormal AChR at the EPs.
In patient 3, the MEPC decayed biexponentially, with one τ MEPC shorter and one 2-fold longer than normal; similarly, noise analysis revealed two time constants, one shorter and one 3-fold longer than normal. These findings suggest expression of γ-AChR as well as a mutant AChR with reduced open duration, or expression of two mutant AChRs, one with a prolonged and one with a reduced open duration.
To summarize, the EP studies reveal severe EP AChR deficiency and a kinetic abnormality of at least a fraction of the AChR channels in each case. In patient 1, patch-clamp recordings are consistent with expression of γ-AChR but τ noise and τ MEPC suggest an additional population of normal duration openings. In patient 2, τ MEPC suggests slightly prolonged channel opening events and patch-clamp recordings resolve two populations of events, one normal and one prolonged. In patient 3, both τ noise and τ MEPC indicate two populations of channel events, one shorter than normal and one prolonged, with the latter again representing γ-AChR.
Mutation analysis
To determine whether the EP AChR deficiency of the CMS patients was caused by mutations in genes encoding AChR subunits, we used genomic DNA to sequence the exons and their flanking intronic regions of the α, β, δ and ε subunit genes in patients 1 and 2 and of the ε subunit gene in patient 3. Patient 1. Direct sequencing revealed two ε subunit gene mutations and three polymorphisms in the α, β and δ subunit genes. The first mutation is a C→T transition in ε exon 4 at nucleotide 190 (εC190T) that converts an arginine codon to a TGA stop codon at position 64 (εR64X) (Fig. 3A) and predicts truncation of the ε subunit in its extracellular domain. The second mutation is a G→T transversion in ε exon 5 at nucleotide 440 (εG440T) that converts an arginine to a leucine codon at position 147 (εR147L) in the extracellular domain of ε (Fig. 3A) . The mutated arginine is conserved across ε subunits of other species, but not in other subunits (Fig. 3C ). As εG440T (εR147L) alters a nucleotide at the end of exon 5, we searched for aberrant splicing due to this mutation using RT-PCR but detected none (data not shown). εR64X causes gain of a ScaI and εR147L loss of a BsaWI site. Restriction analysis of DNA samples demonstrated that patient 1 and his affected brother have both mutations, the asymptomatic mother has εR64X and the asymptomatic father and brother have εR147L (Fig. 3B) . Screening for the mutations by allele-specific PCR revealed neither mutation in 100 normal controls or 58 other unrelated CMS patients. Table 3 lists the three polymorphisms identified in patient 1. Patient 2. Direct sequencing revealed two mutations in the ε subunit gene and six polymorphisms in the α, β and δ subunit genes. The first mutation is duplication in ε exon 2 of 'CTCAC' at nucleotide 123-127 (ε127ins5). ε127ins5 converts Leu-AsnGlu codons to Pro-His-Stop at position 43-45 ( Fig. 4A ) and predicts truncation of the ε subunit in its extracellular domain. Although the ε127ins5 is positioned close to the end of exon 2, no aberrant splicing was detected by RT-PCR spanning the mutation (data not shown). The second mutation was a C→T transition in ε exon 7 at nucleotide 734 (εC734T) that converts a proline to a leucine codon at position 245 (εP245L) (Fig. 4A ). The mutated proline is part of the palindromic sequence marking the C-terminal end of the M1 domain and is conserved across all species and subunits ( Fig. 2C ). ε127ins5 causes loss of a BslI and εP245L loss of a MspI site. Restriction analysis of DNA samples demonstrated that patient 2 and her affected brother have both mutations, the asymptomatic maternal grandmother has no mutation and the asymptomatic mother and father have ε127ins5 and εP245L, respectively (Fig. 4B ). Screening for ε127ins5 by restriction analysis and for εP245L by allele-specific PCR revealed neither mutation in 100 normal controls or 58 other unrelated CMS patients. Table 3 lists the six polymorphisms identified in patient 2.
Patient 3. Direct sequencing of the ε subunit gene revealed two mutations and no polymorphisms. The first mutation is a frameshifting 7 bp deletion at nucleotides 553-559 (ε553del7) predicting premature termination of translation at codon 191, 18 bp downstream from the site of deletion (Fig. 5A) , and truncation of the ε subunit in its extracellular domain. We previously have observed ε553del7 as a heterozygous and homozygous mutation in two other CMS patients, and have reported this in abstracts (20, 21) . The second mutation is a C→T transition in ε exon 9 at nucleotide 931 (εC931T) that converts an arginine to a tryptophan codon at position 311 (εR311W) (Fig. 5A ). The mutated arginine residue is close to the N-terminal end of the long cytoplasmic loop of the ε subunit and is conserved across all species and all subunits (Fig. 5C ). ε553del7 results in gain of a HinfI site and εR311W in loss of an AciI site. Restriction analysis of DNA samples demonstrated both mutations in patient 3, ε553del7 in her asymptomatic mother and sister and εR311W in her asymptomatic father and two children (Fig. 5B ). Screening for ε553del7 by restriction analysis did not reveal it in 100 normal controls and 56 other CMS patients; and screening for ε311W by allele-specific PCR did not reveal it in 100 normal controls and 58 other CMS patients.
To summarize, each of three CMS patients carries two recessive and heteroallelic ε subunit gene mutations. One mutation in each patient (εR64X, ε127ins5 and ε553del7) generates a nonsense codon, and one in each (εR147L, εP245L and εR311W) a missense codon. Figure 6 shows a schematic representation of the mutations in the ε subunit.
Expression studies of mutant ε subunits
AChR expression and affinity for ACh. To gain further insight into the molecular defects produced by the mutant ε subunits, we engineered each mutation into the human ε subunit and co-expressed but reduced expression in the presence of each of the six mutant ε subunits. For each mutation, the number of α-bgt sites was similar to that observed for α 2 βδ 2 pentamers (ε-omitted AChR) ( Fig. 7A and B) , indicating either no incorporation or reduced expression of surface pentamers containing the mutant ε subunits.
To distinguish between lack of incorporation and reduced expression of the mutant subunits, we measured binding of ACh to AChRs harboring the mutant ε subunits by competition against the initial rate of [ 125 I]α-bgt binding. AChRs harboring the three missense mutations, εR147L, εP245L and εR311W, bind ACh in a monophasic manner with dissociation constants coinciding with that of wild-type α 2 βεδ pentamers (Fig. 8A) . Thus, ε subunits harboring the missense mutations incorporate into surface pentamers, but the level of expression is significantly reduced. By contrast, the three nonsense mutations, ε64X, ε127ins5 and ε553del7, give rise to biphasic ACh-binding profiles identical to that obtained with ε-omitted α 2 βδ 2 AChR (Fig. 8B) . The biphasic ACh-binding profile of the α 2 βδ 2 AChR is attributed to loss of cooperative interactions between the two binding sites in the native pentamer, and is therefore a signature for pentamers lacking the ε subunit (13, 30) . Thus, ε subunits harboring the three nonsense mutations do not incorporate into surface pentamers.
To determine whether the three nonsense ε mutations can assemble with the α subunit, one of the earliest steps in AChR assembly, we determined the number of αε complexes from the number of curare-displaceable α-bgt sites in cells permeabilized Bursts are defined as a series of closely spaced openings preceded and followed by closed intervals greater than a specified duration; this duration is taken as the point of intersection of the brief and long closed time components, or 200 µs in these recordings. The smooth curves are fits to the sum of two exponentials for closed and three exponentials for burst duration histograms. Table 1 lists the means of the brief component of closings and long component of bursts, and derived rate constants.
with saponin. The three nonsense mutations fail to assemble with the α subunit, as the number of specific α-bgt-binding sites is similar to that observed in the presence of the α subunit alone (Fig. 7C) . Thus, proteins produced by the three nonsense mutations are either unstable or not capable of associating with the α subunit.
To summarize, the expression studies show that the three nonsense mutations are indeed null mutations and that the surface expression of AChRs harboring the three missense mutations is significantly reduced. The presence of a heteroallelic nonsense and a missense mutation in the ε subunit gene in each patient predicts markedly reduced expression of mutant AChRs at the EP.
Kinetics of activation of AChRs with ε missense mutations.
We studied functional consequences of the missense mutations by recording single channel currents activated by low concentrations (30-100 nM) of ACh from 293 HEK cells transfected with either wild-type or mutant ε plus complementary α, β and δ subunit cDNAs. The current traces show that receptors harboring wild-type ε, εR147L, εP245L and εR311W open several times per activation episode, but that εP245L prolongs and εR311W shortens burst duration (Fig. 9) .
To examine the changes in burst duration quantitatively, we constructed burst duration histograms and fitted them with the sums of exponentials (Fig. 9) . Burst distributions are best described as the sum of three exponential components for wild-type and the three mutant receptors. The two brief components are attributed to receptors with one bound agonist, because they vanish at high ACh concentrations (see Fig. 10 ), whereas the long component corresponds to receptors with two bound agonists. Durations of the brief bursts are not affected by any of the mutations, whereas durations of the long bursts are prolonged by εP245L, shortened by εR311W and not affected by εR147L (Table 4) . Because long bursts predominate during synaptic activity, εR311 is expected to speed up and εP245L to slow down the decay of the EP current. Table 5 .
Closed duration histograms are well described as the sum of two exponentials for wild-type and the three mutant receptors. The long duration component corresponds to periods between independent bursts of openings, and the brief component to transient interruptions of single channel bursts. The mean duration of brief closings is similar for wild-type and the three mutant receptors, indicating similar latencies to reopening for each receptor type (Table 4) .
To identify kinetic steps underlying the changes in burst duration, we describe activation of mutant and wild-type receptors according to the following scheme:
where two agonists A bind to the receptor R with association rates k +1 and k +2 and dissociate from the receptor with rates k -1 and k -2 .
Fully occupied receptors A 2 R open with rate β, and open receptors A 2 R* close with rate α. ACh blocks the open channel with the forward rate k +b , and unblocks with the rate k -b . As described for other species of AChR, the human wild-type and mutant receptors show temporal association of long openings and brief closings (31, 32) . Thus, we assign brief closings to dwells in A 2 R and long openings to dwells in A 2 R* in Scheme 1. Given these assignments, the mean duration of brief closings equals (β + k -2 ) -1 , the number of brief closings per burst of long openings equals β/k -2 , and the mean burst duration equals (1 + β/k -2 )/α (33). These relationships lead to estimates of α, β and k -2 presented in Table 4 . No change in these parameters is detected for εR147L, confirming that it is a kinetically benign mutation. By contrast, εP245L primarily slows the rate of channel closing to prolong burst duration; εP245L is thus a moderate slow channel mutation. Conversely, εR311W slows the rate of channel opening and speeds the rate of agonist dissociation to shorten burst duration; εR311W is thus a moderate fast channel mutation. 
Kinetic analysis of currents elicited by high concentrations of
ACh from AChRs harboring εP245L and εR311W. To determine whether additional steps in Scheme 1 are affected by the mutations, we examined the kinetics of εP245L and εR311W receptors by recording single channel currents over a range of desensitizing ACh concentrations (3-100 µM). Use of desensitizing ACh concentrations allows identification of clusters of events due to a single channel (34) , while use of a range of concentrations allows all the states in Scheme 1 to contribute to the observed dwell times. For wild-type and mutant receptors, openings appear in readily recognizable clusters at concentrations from 3 to 100 µM ACh, with closed intervals within clusters becoming briefer with increasing ACh concentrations (Fig. 10) . We then fitted Scheme 1 to the data by computing the likelihood of each open and closed dwell time, given a set of trial rate constants, and changing the rate constants to maximize the sum of the likelihoods (13, 35) . The results of the fit, shown as smooth curves superimposed on the open and closed duration histograms, reasonably describe the kinetics of wild-type, εP245L and εR311W receptors (Fig. 10) .
Comparison of the kinetics of wild-type and εP245L receptors reveals similar association, dissociation and channel opening rate constants for the two receptor types (Table 5 ). However, the rate constant for channel closing is slowed ∼2-fold, as observed in recordings obtained at limiting low ACh concentrations ( Table 4) . The estimates of α and β for mutant and wild-type were similar in the global and low concentration analyses, but the absolute values of k -2 were consistently greater in the global than in the low concentration analysis (Tables 4 and 5 ). We therefore reanalyzed the global set of data with k -2 fixed to the value obtained at low ACh concentrations, and allowed the other rate constants to vary. Comparison of likelihood values for the two analyses showed clearly superior descriptions of the data with the larger values of k -2 . The global analysis is likely to be most reliable as it comprises considerably more data and describes the kinetics over a wide range of ACh concentrations. Thus, εP245L prolongs bursts solely by decreasing the rate of channel closing.
Comparison of the kinetics of wild-type and εR311W receptors reveals similar rate constants for ACh association and channel closing, but increased rate constants for ACh dissociation and a decreased rate of channel opening. The global and low ACh concentration analyses give essentially the same estimates for β and α, while k -2 is somewhat greater in the global analysis. The opposite changes in β and k -2 lead to a decrease in the ratio β/k -2 , indicating fewer openings per burst. Because α is unchanged, burst duration decreases in proportion to the decrease in β/k -2 , as observed at low ACh concentrations (Table 4) . Thus, εR311W reduces burst duration at the level of single channels, predicting faster decay of the EP current.
Patch-clamp recordings from HEK cells co-transfected with
εR147L and wild-type γ subunit cDNAs. Although εR147L has no kinetic consequences, its expression may be curtailed in adult muscle by competition with the fetal γ subunit. To test this hypothesis, we co-expressed wild-type α, β, γ, δ and εR147L subunits in HEK cells and recorded ACh-induced single channel currents. This revealed predominantly channels with low conductance and long open duration characteristic of γ-AChR, with <2% of the channels having high conductance and brief open durations indicating AChR harboring εR147L. These findings imply that the γ subunit competes with εR147L for incorporation into AChR at the EP.
DISCUSSION
Phenotype effects and pathogenicity of the mutations
Each patient carries a nonsense and a missense mutation on different alleles of the AChR ε subunit gene. Expression studies indicate that none of the three ε subunits with nonsense mutations associates with the α subunit and none incorporates into surface pentamers in the presence of complementary subunits. Thus, these are null mutations, and the clinical phenotype in each patient is defined by the consequences of the corresponding missense mutation. The ε subunits with missense mutations incorporate into surface pentamers but with reduced efficiency. AChRs with these subunits bind ACh with normal affinity and are opened by ACh. Channel kinetics, however, are normal only for εR147L-AChR but not for εP245L-or εR311W-AChRs. The effects of the prolonged bursts caused by εP245L are mitigated by the paucity of AChRs at the EP, but shortening of the burst open duration by εR311W may further impair the safety margin of neuromuscular transmission.
Consequences of the missense mutations εR147L. Our findings, together with previous mutagenesis studies, suggest that εR147L leads to a novel predominance of γ-AChR at the patient EP. εR147L lies between Il45 and T150, two residues crucial for progression of assembly beyond αε dimers (36); our observation of reduced expression in HEK cells suggests that εR147L adversely affects assembly. As indicated by the predominance of γ-AChR in experiments in HEK cells co-expressing γ and εR147L subunits, γ expressed in adult muscle may compete efficiently with εR147L for assembly with complementary subunits. Evidence for this competition mechanism in adult muscle is the predominance of γ-AChR in the MEPC, noise analysis and single channel recordings from patient 1. Persistent γ-AChR is compatible with the recent observation that homozygous deletion of the ε subunit gene in mice results in persistent, though reduced γ subunit gene expression in the adult mutants (37) .
εR311W. This mutation borders the carboxy-terminus of the M3 transmembrane domain where the long cytoplasmic loop begins. In this location, εR311 is an example of the 'positive inside' rule for membrane protein topology in which positively charged residues contribute to orienting and anchoring the adjacent transmembrane domain (38) . Our findings that εR311W reduces channel open durations by slowing channel opening and speeding agonist dissociation indicate a perturbation of the gating apparatus and the ACh-binding site to which it is linked. The kinetic effect of εR311W may be related to the contribution of the long cytoplasmic loop to the fetal-to-adult change in AChR kinetics (39) . Owing to its location between transmembrane and cytoplasmic domains, εR311W may reduce surface expression by impairing folding during AChR assembly. The expression studies also indicate that the long components of τ MEPC and τ noise observed at EPs of patient 3 are not due to mutant channels but rather to fetal γ-AChR. As in the case of εR147L, the fetal γ subunit may compete efficiently with the ε subunit harboring εR311W for α, β and δ subunits.
εP245L. The mutated P245 residue is part of the palindromic sequence thought to mark the carboxy-terminus of the M1 transmembrane domain. The structural contribution of P245 may be to align the M1 domain within the membrane and to produce a kink on the cytoplasmic face of the AChR, allowing the adjacent M2 channel domain to reverse direction and extend back across the membrane. Our expression studies indicate that εP245L increases channel open duration by selectively slowing the rate of channel closing, perhaps owing to perturbation of the channel gating apparatus. The reduced efficiency of surface expression may result from impaired folding during assembly of the εP245L-AChR. The presence of εP245L in EP AChRs is evidenced by a population of prolonged channel opening episodes recorded from EPs of patient 2.
AChR species at the endplate
The sparse AChRs expressed at each patient's EPs probably comprise different species of the receptor macromolecule. These include AChR harboring the missense mutations εR147L, εP245L and εR311W in patients 1, 2, and 3, respectively, γ-AChR in patients 1 and 3, and possibly ε-omitted α 2 βδ 2 AChR in any of the three patients. We previously reported a low level of γ-AChR expression at the EP in another patient with severe AChR deficiency due to heteroallelic null mutations in the long cytoplasmic loop of ε (19), and proposed that γ-AChR expression may serve as the means of phenotypic rescue from potentially fatal mutations in the ε gene. As the ε subunit gene is located on chromosome 17 (40) and the γ subunit gene on chromosome 2 (41), the persistent γ expression in these diseases is not due to altered regulation of a single gene cluster by a common locus control region.
As regards the expression of α 2 βδ 2 AChR, even if this species of AChR were expressed, it may not function efficiently due to its reduced affinity for ACh (13) . The kinetic signature of the human α 2 βδ 2 AChR is still unknown, and this precludes identifying it at the EP by single channel recordings.
Compensatory mechanisms
In addition to persistent expression of the fetal γ-AChR at the EPs (as in patients 1 and 3), other mechanisms may also help to improve neuromuscular transmission in our patients. The nerve sprouts, associated with the multiple focal EP regions (see Fig.  1A ), have an imprinting influence on the underlying nuclei to induce transcription of AChR subunit genes (14, 42, 43) , augmenting the total amount of EP AChR. A trophic influence of muscle on nerve may be at work in increasing the number of ACh quanta released by nerve impulse (as in patients 2 and 3) ; alternatively, the increased quantal release stems from an increased number of active zones per EP due to the increased number of EP regions. Despite these compensatory mechanisms, the safety margin of neuromuscular transmission remains severely compromised by the AChR deficiency.
Relationship of the present syndromes to other postsynaptic CMS
The postsynaptic CMS are associated with a kinetic abnormality of the AChR, a deficiency of the AChR or both (1) . The kinetic abnormalities are associated with mutations in AChR subunits that enhance (the slow channel CMS) (10) (11) (12) 44) or reduce (the low-affinity fast channel syndrome) (13) the response to ACh.
The slow channel syndromes stem from dominant missense mutations that confer a pathological gain of function. The resulting prolonged opening episodes of the AChR channel overload the junctional sarcoplasm with cations, causing an EP myopathy with secondary loss of AChR from degenerating junctional folds, and cause a depolarization block due to staircase summation of prolonged EP potentials (10) (11) (12) . HEK cells expressing slow-channel mutations produce either normal (11, 12) or only modestly reduced (10) amounts of AChR. Therefore, in the slow channel syndromes, the EP AChR deficiency is due predominantly to the EP myopathy and not to diminished expression of the mutated subunit.
The low-affinity fast channel syndrome results from a missense mutation that causes loss of function and requires a heteroallelic null mutation in the same subunit gene in order to become clinically manifest. There is no EP AChR deficiency, the structural integrity of the postsynaptic region is maintained, but AChR opening episodes are fewer and shorter than normal owing to a decreased affinity of AChR for ACh (13) .
The CMS described in this report stem from nonsense and missense mutations in different alleles of the ε subunit gene. Only ε subunits carrying the missense mutations are expressed, but with reduced efficiency, and this results in severe EP AChR deficiency. The integrity of the postsynaptic region is preserved but the EPs now consist of multiple small regions that probably increase the area of synaptic contact. The γ-AChR expression in patients 1 and 3 results in prolonged channel openings but the postsynaptic region is protected from cationic overloading because the synaptic current is restricted by the severe AChR deficiency, the γ-AChR channel opens to a reduced conductance and γ-AChR passes 3-fold less calcium than the mature ε-AChR (45).
MATERIALS AND METHODS
Muscle specimens
Specimens of intercostal muscle were obtained intact from origin to insertion from patients and from control subjects without muscle disease undergoing thoracic surgery. All human studies were in accord with the guidelines of the Institutional Review Board of the Mayo Clinic.
Endplate studies
Morphology and counts of AChR per EP. For electron microscopy, EPs were localized and analyzed by established methods (25) . Peroxidase-labeled α-bgt was used for the ultrastructural localization of AChR (46) . The number of AChRs per EP was measured with 125 I-labeled α-bgt, as previously described (47) .
Intracellular microelectrode studies. MEPC and EPP recordings, estimates of the number of transmitter quanta released by nerve impulse and analysis of the ACh-induced current noise were carried out as previously described (8, 47) .
Patch-clamp recordings from EP AChRs. These were performed in the cell-attached mode by a slight modification of the previously described method (10, 48) . For all patches, the membrane potential was set to -80 mV; when possible, recordings were also obtained at -40, -120 and -160 mV. These membrane potentials were achieved by applying a corresponding potential to the patch pipet, and assuming a resting potential of 0 mV; a null resting potential was confirmed by the absence of detectable channel events with 0 mV applied to the pipet. Channel currents were recorded using an Axopatch 200A amplifier (Axon Instruments), and analyzed at a final bandwidth of 5.8 kHz using the program PCLAMP 6 (Axon Instruments) or MacTac (Instrutech). Burst durations were determined by grouping openings separated by a specified closed time that misclassifies equal proportions of long closed times within bursts and short intervals between bursts (31). Dwell time histograms were plotted on logarithmic abscissa and fitted to the sum of exponentials by maximum likelihood (49) .
Mutation analysis
mRNA and DNA samples. Genomic DNA was isolated from proteinase/SDS digest of blood or muscle by phenol-chloroform extraction followed by ethanol precipitation (50) . mRNA was obtained using the Micro-FastTrack mRNA isolation kit (Invitrogen). First-strand cDNA was prepared from mRNA by using random hexamer primers with the cDNA Cycle kit (Invitrogen) and following the instructions of the manufacturer.
Polymerase chain reaction procedures. PCR primers were designed to amplify exons with their flanking regions from each AChR subunit as previously described (10) . Published cDNA sequences of the human ε subunit (40) were used to design cDNA primers.
Sequence analysis. PCR-amplified fragments of genomic DNA or cDNA were purified by Wizard PCR Preps (Promega). Plasmids were purified by QIAwell 8 Plus Plasmid kit (Qiagen). DNA fragments and plasmids were sequenced with an Applied Biosystems model 377 DNA sequencer using fluorescently labeled dideoxy terminators.
Restriction enzyme analysis and allele-specific PCR. We screened for all six mutations by restriction analysis in the patients' relatives, and we screened for ε127ins5 and ε553del7 by restriction analysis and for εR64X, εR147L, εP245L and R311W by allele-specific PCR in other CMS patients and controls. The primers for amplifying DNA fragments for restriction analysis and for allele-specific PCR and the PCR conditions are available upon request.
Expression studies
Construction and expression of human wild-type and mutant AChRs. Human α and δ subunit cDNAs were generously provided by Dr Jon Lindstrom (51, 52) . The β and ε subunit cDNAs were cloned from normal human skeletal muscle as described previously (13) . cDNA for the normal human γ subunit was cloned from a nested RT-PCR product amplified from normal muscle with Pfu DNA polymerase (Stratagene). The first primers for amplification were 5′-CTGCCCCAGACCTTGGAG-3′ (nucleotides -124 to -107) and 5′-GAGAACGTGGCTGATAAG-ACT-3′ (nucleotides 1540-1560); the nested primers were 5′-cggccggaattcTGTTGTCCCACCCCTGTCAC-3′ (nucleotides -105 to -86) and 5′-cggccggaattcCTCCCACATGCCCCA-CAGTG-3′ (nucleotides 1499-1518), the artificial lower case sequences serving to introduce an EcoRI site into the PCR product. The nested PCR product spanned nucleotides -105 to 1518, whereas the coding region of the γ subunit extends from -66 to 1485. The nested PCR product was digested with EcoRI, gel purified and ligated into pBluescript II SK(-) (Stratagene). Sequencing of our γ clone revealed no mutation or polymorphism when compared with the reference sequence of human γ subunit gene (GenBank accession nos, X01715-X01721 and X04759) (53) .
All five cDNAs were subcloned into the CMV-based expression vector pRBG4 (54) for expression in 293 HEK cells.
The identified mutations were introduced into the pRBG4 with the ε subunit cDNA insert using QuickChange Site-Directed Mutagenesis Kit (Stratagene). We synthesized two complementary oligonucleotides for each mutation. The sense sequences of the synthesized oligonucleotides were 5′-GATTGGCAGGATTACtG-ACTCAACTACAGC-3′ for εR64X, 5′-CGCTTATTTTCCtCTC-TCAGACGTACAATG-3′ for εR147L, 5′-TCACCCTGACGAATCTCATCTCACctcacTGAATGAAAAAGAGGAGAC-3′ for ε127ins5, 5′-CCTACTTCCTGCtGGCGCAGGCCGGC-3′ for εP245L and 5′-CAACGTGTCCCAGtGGACGCCCACCAC-3′ for εR311W. Lower case letters represent artificial nucleotides used to introduce the respective mutations. The site-directed mutagenesis reaction mixture contained 50 ng of pRBG4 vector harboring the ε subunit cDNA insert, 125 ng of oligonucleotide, 50 nM each dNTP, 10% dimethyl sulfoxide, 2.5 U of Pfu DNA polymerase and the supplied buffer in 50 µl. To synthesize nicked circular double-stranded DNA with the mutation, temperature cycling was carried out in Thermal Cycler 480 (Perkin Elmer) with the following conditions: denaturation at 95_C for 30 s; 12 cycles of 95_C for 30 s, 55_C for 1 min, and 68_C for 12 min. The reaction mixture was then incubated with 10 U of DpnI at 37_C for 1 h to digest the methylated parental plasmids without the mutation. The nicked circular double-stranded DNA was introduced in XL1-Blue competent cells. The resultant pRBG4 vector containing the mutation was proliferated in LB broth and purified with Plasmid Maxi Kit (Qiagen) for transfection into 293 HEK cells. The presence of the desired mutation and the absence of unwanted mutations was confirmed by sequencing the entire insert.
A pRBG4 vector with the ε553del7 mutation was obtained by subcloning an RT-PCR product amplified from muscle mRNA of another patient who had the same mutation (20) . The entire coding region of the ε subunit was amplified from mRNA using the nested PCR method with the same primers that we used to clone the wild-type ε subunit gene (13) . The artificially introduced EcoRI sites at both ends of the nested RT-PCR product were digested with EcoRI and the mutant cDNA was then cloned into a pRBG4 vector.
Human embryonic kidney fibroblasts (293 HEK) were transfected with mutant or wild-type AChR subunit cDNAs using calcium phosphate precipitation as described (39) . where Y is the fractional occupancy by ACh, K ov is an overall dissociation constant for a monophasic binding profile, K A and K B are intrinsic dissociation constants for two binding sites and fract A is the fraction of sites with dissociation constant K A .
Patch-clamp recordings from AChRs expressed in HEK cells.
Recordings were obtained in the cell-attached configuration, with a membrane potential of -70 mV, a temperature of 22_C and with bath and pipet solutions containing (mM): KCl 142, NaCl 5.4, CaCl 2 1.8, MgCl 2 1.7, HEPES 10, pH 7.4 (13, 39) . Single channel currents were recorded using an Axopatch 200A at a bandwidth of 50 kHz, digitized at 100 kHz, transferred to a Macintosh computer using the program Acquire (Instrutech Corp.) and detected by the half-amplitude threshold criterion using the program MacTac (Instrutech Corp.) at a final bandwidth of 10 kHz. Open and closed duration histograms were constructed using a logarithmic abscissa and square root ordinate (49) , and fitted to the sum of exponentials by maximum likelihood. For kinetic analysis according to Scheme 1, clusters of openings corresponding to a single channel were identified and then examined for homogeneity in terms of open probability and mean open duration as previously described (13) . The resulting durations of open and closed intervals were transferred to an IBM RS6000 computer and analyzed according to Scheme 1 using an interval-based maximum likelihood method that incorporated corrections for missed events (35) . Single channel dwell times, obtained from single patches at several concentrations of ACh, were fitted simultaneously. After fitting, error estimates for each parameter were determined as described (35) . Open and closed duration histograms were calculated from the fitted rate constants and superimposed on the experimental dwell time histograms.
